ATE371445T1 - Verfahren zur prävention und/oder behandlung von asthma mit parabromophenacyl bromide (pbpb) - Google Patents
Verfahren zur prävention und/oder behandlung von asthma mit parabromophenacyl bromide (pbpb)Info
- Publication number
- ATE371445T1 ATE371445T1 AT02783467T AT02783467T ATE371445T1 AT E371445 T1 ATE371445 T1 AT E371445T1 AT 02783467 T AT02783467 T AT 02783467T AT 02783467 T AT02783467 T AT 02783467T AT E371445 T1 ATE371445 T1 AT E371445T1
- Authority
- AT
- Austria
- Prior art keywords
- pbpb
- preventing
- treating asthma
- parabromophenacyl bromide
- parabromophenacyl
- Prior art date
Links
- FKJSFKCZZIXQIP-UHFFFAOYSA-N 2-bromo-1-(4-bromophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(Br)C=C1 FKJSFKCZZIXQIP-UHFFFAOYSA-N 0.000 title abstract 4
- 208000006673 asthma Diseases 0.000 title abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2002/005065 WO2004050071A1 (en) | 2002-12-02 | 2002-12-02 | A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371445T1 true ATE371445T1 (de) | 2007-09-15 |
Family
ID=32375339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02783467T ATE371445T1 (de) | 2002-12-02 | 2002-12-02 | Verfahren zur prävention und/oder behandlung von asthma mit parabromophenacyl bromide (pbpb) |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040106685A1 (de) |
| EP (1) | EP1569631B1 (de) |
| JP (1) | JP4566750B2 (de) |
| CN (1) | CN100398101C (de) |
| AT (1) | ATE371445T1 (de) |
| AU (1) | AU2002347536B2 (de) |
| CA (1) | CA2508307C (de) |
| DE (1) | DE60222185T2 (de) |
| WO (1) | WO2004050071A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017096049A1 (en) | 2015-12-03 | 2017-06-08 | The University Of North Carolina At Pembroke | Materials for cathepsin b enhancement and methods of use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4933365A (en) * | 1989-01-25 | 1990-06-12 | American Home Products Corporation | Phospholipase A2 inhibitors |
| WO1991012237A1 (en) * | 1990-02-08 | 1991-08-22 | Eisai Co., Ltd. | Benzenesulfonamide derivative |
| US5622832A (en) * | 1990-02-28 | 1997-04-22 | Genetics Institute, Inc. | Arachidonic acid releasing phospholipase A2 enzyme and methods of use |
| IL101507A0 (en) * | 1991-04-17 | 1992-12-30 | Lilly Co Eli | Compounds,vectors and methods for expressing human,cytosolic phospholipase a2 |
| US6486170B1 (en) * | 1994-02-04 | 2002-11-26 | Arch Development Corporation | Phospholipase A2 inhibitors as mediators of gene expression |
| JPH08325154A (ja) * | 1995-03-31 | 1996-12-10 | Mitsui Toatsu Chem Inc | 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼａ２阻害剤 |
| AU6381496A (en) * | 1995-06-07 | 1996-12-30 | Athena Neurosciences, Inc. | Therapeutic inhibition of phospholipase a2 in neurodegenerat ive disease |
| US5663059A (en) * | 1996-05-10 | 1997-09-02 | Incyte Pharmaceuticals, Inc. | Human phospholipase inhibitor |
| JPH11269077A (ja) * | 1998-03-19 | 1999-10-05 | Maruho Co Ltd | ホスホリパーゼａ２阻害用医薬組成物 |
| JP2002080368A (ja) * | 2000-06-19 | 2002-03-19 | Nippon Soda Co Ltd | 抗炎症薬 |
-
2002
- 2002-12-02 CA CA2508307A patent/CA2508307C/en not_active Expired - Fee Related
- 2002-12-02 AU AU2002347536A patent/AU2002347536B2/en not_active Ceased
- 2002-12-02 JP JP2004556565A patent/JP4566750B2/ja not_active Expired - Fee Related
- 2002-12-02 CN CNB028301277A patent/CN100398101C/zh not_active Expired - Fee Related
- 2002-12-02 EP EP02783467A patent/EP1569631B1/de not_active Expired - Lifetime
- 2002-12-02 AT AT02783467T patent/ATE371445T1/de not_active IP Right Cessation
- 2002-12-02 WO PCT/IB2002/005065 patent/WO2004050071A1/en not_active Ceased
- 2002-12-02 DE DE60222185T patent/DE60222185T2/de not_active Expired - Lifetime
-
2003
- 2003-03-17 US US10/388,662 patent/US20040106685A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4566750B2 (ja) | 2010-10-20 |
| EP1569631A1 (de) | 2005-09-07 |
| DE60222185D1 (de) | 2007-10-11 |
| DE60222185T2 (de) | 2008-06-12 |
| CN1720032A (zh) | 2006-01-11 |
| CA2508307C (en) | 2010-05-25 |
| CA2508307A1 (en) | 2004-06-17 |
| CN100398101C (zh) | 2008-07-02 |
| EP1569631B1 (de) | 2007-08-29 |
| WO2004050071A1 (en) | 2004-06-17 |
| US20040106685A1 (en) | 2004-06-03 |
| AU2002347536B2 (en) | 2008-02-21 |
| AU2002347536A1 (en) | 2004-06-23 |
| JP2006510628A (ja) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| DE69902154D1 (de) | Eisen-dextran verbindung zur verwendung als komponente in einer therapeutischen zusammensetzung zur behandlung oder prophylaxe von eisenmangel, sowie verfahren zur herstellung der eisen-dextran verbindung und ihre anwendung zur herstellung einer parenteral anwendbaren therapeutischen zubereitung. | |
| DE69528475D1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| ATE250932T1 (de) | Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer | |
| ATE238307T1 (de) | Substituierte porphyrinen | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| DE69711034D1 (de) | Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen | |
| ATE411016T1 (de) | Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten | |
| DE602004003587D1 (de) | Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite | |
| DE69929464D1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
| ATE520781T1 (de) | Verfahren zur veränderung des gehalts von speicherstoffen in pflanzen | |
| DE69429299D1 (de) | Verwendung von Tachykinin-Antagonisten zur Behandlung von Erbrechen | |
| ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
| ATE345811T1 (de) | Methoden zur verwendung von neurotrophin 3 (nt-3) zur behandlung von gastrointestinalen hypomobilitätsstörungen | |
| ATE278441T1 (de) | Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind | |
| DE69927602D1 (de) | Verfahren zur herstellung von vitaminpulvern | |
| DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
| DE60015791D1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE371445T1 (de) | Verfahren zur prävention und/oder behandlung von asthma mit parabromophenacyl bromide (pbpb) | |
| ATE501730T1 (de) | Verfahren zur behandlung von psoriasis unter verwendung eines il-17d antagonisten | |
| EP1056458A4 (de) | Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen | |
| ATE409732T1 (de) | Methoden zur vorbehandlung von schuhen | |
| ATE314066T1 (de) | Verwendung von buprenorphin zur therapie der harninkontinenz | |
| ATE357914T1 (de) | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien | |
| DE60219761D1 (de) | Verwendung von quetiapin für die behandlung von kokain-abhängigkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |